<p>The invention provides small molecule protease inhibitors that are chemically modified by covalent attachment of water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the small molecule protease inhibitor not attached to the water-soluble oligomer.</p>
